|
COPS7A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.802300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.284600E-01 |
| Normal-vs-Stage2 |
4.832800E-01 |
| Normal-vs-Stage3 |
2.728600E-01 |
| Normal-vs-Stage4 |
3.428000E-01 |
| Stage1-vs-Stage2 |
1.414430E-01 |
| Stage1-vs-Stage3 |
5.456600E-01 |
| Stage1-vs-Stage4 |
4.193200E-01 |
| Stage2-vs-Stage3 |
1.664440E-01 |
| Stage2-vs-Stage4 |
2.481000E-01 |
| Stage3-vs-Stage4 |
7.626400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.514630E-01 |
| Normal-vs-AfricanAmerican |
5.296000E-02 |
| Normal-vs-Asian |
8.682200E-01 |
| Caucasian-vs-AfricanAmerican |
3.942200E-01 |
| Caucasian-vs-Asian |
5.828200E-01 |
| AfricanAmerican-vs-Asian |
3.825600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.519000E-01 |
| Normal-vs-Female |
2.943600E-02 |
| Male-vs-Female |
2.595200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.478000E-01 |
| Normal-vs-Extreme_Weight |
3.933400E-01 |
| Normal-vs-Obese |
1.008770E-01 |
| Normal-vs-Extreme_Obese |
9.790200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.870800E-01 |
| Normal_Weight-vs-Obese |
4.510400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.545200E-01 |
| Extreme_Weight-vs-Obese |
5.240800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.221200E-01 |
| Obese-vs-Extreme_Obese |
4.631200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.502200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.217800E-03 |
| Normal-vs-Age(61-80Yrs) |
8.962200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.604800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.816800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.516000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.287800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.916800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.386570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.155200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.524670E-03 |
| Normal-VS-Type2 PRCC |
1.772820E-01 |
| Normal-VS-KIRP CIMP |
5.599800E-01 |
| Normal-VS-Unclassified PRCC |
3.841600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.797200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.344000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.572400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.779400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.415900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.222970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.740800E-01 |
| Normal-vs-N1 |
8.522200E-01 |
| Normal-vs-N2 |
4.324400E-02 |
| N0-vs-N1 |
9.941000E-01 |
| N0-vs-N2 |
1.028470E-02 |
| N1-vs-N2 |
3.563700E-02 |
|
|
